The hematopoietic stem cell transplant comorbidity index can predict for 30-day readmission following autologous stem cell transplant for lymphoma and multiple myeloma
Jaglowski, S M, Ruppert, A S, Hofmeister, C C, Elder, P, Blum, W, Klisovic, R, Vasu, S, Penza, S, Efebera, Y A, Benson, D M, Devine, S M, Andritsos, L A
Published in Bone marrow transplantation (Basingstoke) (01.10.2014)
Published in Bone marrow transplantation (Basingstoke) (01.10.2014)
Get full text
Journal Article
Circulating miRNA markers show promise as new prognosticates for multiple myeloma
Rocci, A, Hofmeister, C.C, Geyer, S, Stiff, A, Gambella, M, Cascione, L, Guan, J, Benson, D.M, Efebera, Y.A, Talabere, T, Dirisala, V, Smith, E.M, Omede, P, Isaia, G, De Luca, L, Rossi, D, Gentili, S, Uccello, G, Consiglio, J, Ria, R, Benevolo, G, Bringhen, S, Callea, V, Weiss, B, Ferro, A, Magarotto, V, Alder, H, Byrd, J.C, Boccadoro, M, Marcucci, G, Palumbo, A, Pichiorri, F
Published in Leukemia (01.09.2014)
Get full text
Published in Leukemia (01.09.2014)
Journal Article
PF608 ANCHOR (OP‐104): A PHASE 1 STUDY UPDATE OF MELFLUFEN AND DEXAMETHASONE PLUS BORTEZOMIB OR DARATUMUMAB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS REFRACTORY TO AN IMID OR A PROTEASOME INHIBITOR
Pour, L., Efebera, Y.A., Granell, M., Hajek, R., Oriol, A., Delaunay, J., Le Du, K., Eveillard, J.‐R., Karlin, L., Maisnar, V., Martinez‐Lopez, J., Mateos, M.‐V., Norkin, M., Ribrag, V., Richardson, P.G., Straub, J., Byrne, C., Jacques, C., Sydvander, M., Ocio, E.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article